Travere Therapeutics Inc. (TVTX) at a glance

Travere Therapeutics Inc. (TVTX) is a mid-cap Healthcare company. It trades at $66.17, with a -4% profit margin and revenue growth of 55.6%. It does not pay a dividend. Vestovix scores it 55/100 overall. Its strongest dimension is Growth (94/100) and its weakest is Value (30/100). Its volatility is roughly in line with the market.

Price

$66.17

Market cap

$4.84B

P/E ratio

n/a

Dividend yield

None

Beta

1.14

52-week range

$17.27 to $67.85